http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009511512-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-565
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-585
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-57
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
filingDate 2006-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-03-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009511512-A
titleOfInvention Process for the manufacture of a single phase pharmaceutical product for oral treatment of dysfunctional uterine bleeding
abstract The present invention relates to a method of manufacturing a single phase pharmaceutical product for oral treatment of dysfunctional uterine bleeding, wherein an oral single phase combination of dienogest and ethinyl estradiol at a low dose is one or more pharmaceutically acceptable doses. Used with a formant / carrier to achieve complete conversion in the absence of hormone and moderate growth of the endometrium with short and slight retrograde bleeding through hormone levels present at a constant level. The
priorityDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005113350-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1535618-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002543155-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6451778-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002543158-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005007112-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004112797-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005032758-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419575990
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554137
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419541440
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449247579
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9571023
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419503777
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9548815
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5360970
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5991
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID492274
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68861

Total number of triples: 42.